Ads

 

Ads

 

Ads

 

World Top 500 Companies by Revenue as of 2023

  1. Rank by Revenue in Search Criteria: 5451Annual Revenue in USD: Annual Operating Income in USD: Annual Net Income in USD: Annual Results for Period Ending: World Rank (Jul-30-2023): 4,777Market Cap (Jul-30-2023): Employee Count: Employee Count as of Date:
    Company Profile:

    Synthorx is a Clinical Stage Biotechnology company. It is focused on prolonging and improving the lives of people with cancer and autoimmune disorders and platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics referred to as Synthorins. The headquarters is in USA.

    Assore delisted from JSE in March-2020.

  2. Rank by Revenue in Search Criteria: 5452Annual Revenue in USD: Annual Operating Income in USD: -134 Million USDAnnual Net Income in USD: -129 Million USDAnnual Results for Period Ending: For year ending December-2018World Rank (Jul-30-2023): 4,519Market Cap (Jul-30-2023): Employee Count: 250Employee Count as of Date: As of 2020
    Company Profile:

    Audentes Therapeutics is a Genetic Medicines company. The company overall incidence is estimated to be approximately 1 in 40,000 births although frequency and disease progression varies with age of onset, ethnicity and geography. The headquarters is in USA.

    Astellas completes acquision of Audentes in Jan 2020 for approximately 3 Billion USD.

  3. Rank by Revenue in Search Criteria: 5453Annual Revenue in USD: Annual Operating Income in USD: Annual Net Income in USD: Annual Results for Period Ending: World Rank (Jul-30-2023): 2,069Market Cap (Jul-30-2023): Employee Count: 4,700Employee Count as of Date: As on 2019
    Company Profile:
    TOKOPEDIA is eCommerce and online shopping services providing company with headquarters is in Indonesia.
  4. Rank by Revenue in Search Criteria: 5454Annual Revenue in USD: Annual Operating Income in USD: Annual Net Income in USD: Annual Results for Period Ending: World Rank (Jul-30-2023): 2,207Market Cap (Jul-30-2023): 7 Billion USDEmployee Count: Employee Count as of Date:
    Company Profile:

    Celltrion Healthcare Co., Ltd. engages in the manufacture, processing, and sale of biosimilar and biological medicines to patients around the world. Its products include Remsima, a monoclonal antibody biosimilar that is used for rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, Crohn's disease in children, psoriasis, and psoriatic arthritis; Truxima, which is used for lymphoma, chronic lymphocytic leukemia, Heaquarters is in South Korea.

  5. Rank by Revenue in Search Criteria: 5455Annual Revenue in USD: Annual Operating Income in USD: -190 Million USDAnnual Net Income in USD: -185 Million USDAnnual Results for Period Ending: For year ending December-2022World Rank (Jul-30-2023): 2,731Market Cap (Jul-30-2023): 6 Billion USDEmployee Count: 163Employee Count as of Date: As on 2022
    Company Profile:

    Iveric Bio is an Innovative Biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with significant unmet medical needs. Iveric Bio 163 employees as on 2022. The headquarters is in USA.

    Astellas Pharma Inc. (TSE: 4503) has completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE) on July 11, 2023 and the acquisition price of the same was 5.9 billion USD.

  6. Rank by Revenue in Search Criteria: 5456Annual Revenue in USD: Annual Operating Income in USD: Annual Net Income in USD: Annual Results for Period Ending: World Rank (Jul-30-2023): 2,913Market Cap (Jul-30-2023): Employee Count: 19,342Employee Count as of Date: As on December-2020
    Company Profile:

    Unione di Banche Italiane is a Banking Holding company. It has a multiregional coverage with 1,565 branches in Italy of which 581 in Lombardy and 144 in Piedmont and a significant presence in the most dynamic regions of Central Italy and in Southern Italy.

Share

Ads